| Kyle James Babinski, DO | |
|
357 Williamson Rd, Mooresville, NC 28117-5935 | |
| (704) 664-7783 | |
| Not Available |
| Full Name | Kyle James Babinski |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 357 Williamson Rd, Mooresville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174011381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2021-01684 (North Carolina) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gentiva Health Services | Hickory, NC | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Healthcare Pa | 9638070683 | 222 |
News Archive
In her latest piece on the New York Times' "Opinionator" blog, author and journalist Tina Rosenberg argues that the terms of Gilead's recent agreement with the Medicines Patent Pool is "confirmation of a dangerous new trend: middle-income countries as a target market for drug makers."
Rather than functioning as substitutes for hospital-based emergency departments, freestanding emergency departments have increased local market spending on emergency care in three of four states' markets where they have entered, according to a new paper by experts at Rice University.
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010.
Fibronectin plays a major role in wound healing and embryonic development. The protein, which is located in the extracellular matrix of cells, has also been linked to pathological conditions including cancer and fibrosis.
› Verified 2 days ago
| Entity Name | Piedmont Healthcare Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912999897 PECOS PAC ID: 9638070683 Enrollment ID: O20040114000339 |
News Archive
In her latest piece on the New York Times' "Opinionator" blog, author and journalist Tina Rosenberg argues that the terms of Gilead's recent agreement with the Medicines Patent Pool is "confirmation of a dangerous new trend: middle-income countries as a target market for drug makers."
Rather than functioning as substitutes for hospital-based emergency departments, freestanding emergency departments have increased local market spending on emergency care in three of four states' markets where they have entered, according to a new paper by experts at Rice University.
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010.
Fibronectin plays a major role in wound healing and embryonic development. The protein, which is located in the extracellular matrix of cells, has also been linked to pathological conditions including cancer and fibrosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle James Babinski, DO Po Box 1845, Statesville, NC 28687-1845 Ph: (704) 873-4277 | Kyle James Babinski, DO 357 Williamson Rd, Mooresville, NC 28117-5935 Ph: (704) 664-7783 |
News Archive
In her latest piece on the New York Times' "Opinionator" blog, author and journalist Tina Rosenberg argues that the terms of Gilead's recent agreement with the Medicines Patent Pool is "confirmation of a dangerous new trend: middle-income countries as a target market for drug makers."
Rather than functioning as substitutes for hospital-based emergency departments, freestanding emergency departments have increased local market spending on emergency care in three of four states' markets where they have entered, according to a new paper by experts at Rice University.
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010.
Fibronectin plays a major role in wound healing and embryonic development. The protein, which is located in the extracellular matrix of cells, has also been linked to pathological conditions including cancer and fibrosis.
› Verified 2 days ago
Dr. Eva A Imperial, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 114 Gateway Blvd Ste B, Mooresville, NC 28117 Phone: 980-435-0409 | |
Alissandro Roque Castillo, MD, MBA Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 478 Williamson Rd, Suite B, Mooresville, NC 28117 Phone: 704-662-3627 Fax: 704-662-3229 | |
Dr. Rebecca Mcelhannon Panuski, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Corporate Park Dr, Suite 200 & 300, Mooresville, NC 28117 Phone: 704-235-9090 Fax: 704-235-9101 | |
Dr. Bruce S Mather, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Corporate Park Dr, Suite 200 & 300, Mooresville, NC 28117 Phone: 704-235-9090 Fax: 704-235-9101 | |
Dr. Craig Lincoln Anthony, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Corporate Park Dr Ste 200&300, Mooresville, NC 28117 Phone: 704-235-9090 Fax: 704-235-9101 | |
Amber Hicks-thibodeau, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 798 Oak Ridge Farm Hwy. Suite A, Mooresville, NC 28115 Phone: 704-658-0011 Fax: 704-658-0012 | |
Emily Marie Nabors, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 142 Professional Park Dr Ste 300, Mooresville, NC 28117 Phone: 704-696-2083 Fax: 704-924-7742 |